Lv1
40 积分 2025-12-17 加入
Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy: Results from a randomized, double-blind, placebo-controlled phase III study (TRACES)
2个月前
已完结
Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion
5个月前
已完结
Role of cyclin-dependent kinase 4/6 inhibitors in the current and future eras of cancer treatment
5个月前
已完结
Cell Cycle Progression and Synchronization: An Overview
6个月前
已完结
Cyclin-dependent kinase 4/6 inhibitors: what have we learnt across studies, therapy situations and substances
7个月前
已完结
Trilaciclib: First Approval
8个月前
已完结
New Drug Protects Against Myelosuppression Secondary to Lung Cancer Chemotherapy
8个月前
已完结
皖公网安备34019202002308
